Based on 1 analysts giving stock ratings to Intelligent Bio Solutions Inc in the past month.
In the current month, INBS has received 0 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. INBS average Analyst price target in the last month is 12.000.
Based on analysts' estimates, INBS EPS is projected to reach -1.360 in FY2027Q2, following reported EPS of -0.859 in FY2027Q1. Track earnings expectations against reported figures to see how profitability is evolving.
The market expectation was USD -0.86, while Intelligent Bio Solutions IncINBS's earnings per share (EPS) for the previous quarter was USD -1.56. EPS for the next quarter is expected at USD -1.36.